We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 15.49%
3 Technology 15.18%
4 Industrials 11.77%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNC icon
151
PNC Financial Services
PNC
$102B
$2.71M 0.04%
31,702
+4,045
+15% +$344K
CAT icon
152
Caterpillar
CAT
$409B
$2.65M 0.04%
26,756
+375
+1% +$39.8K
PFE icon
153
Pfizer
PFE
$145B
$2.64M 0.04%
94,242
+3,031
+3% +$85.1K
MON
154
DELISTED
Monsanto Co
MON
$2.64M 0.04%
23,457
+329
+1% +$38.5K
KDP icon
155
Keurig Dr Pepper
KDP
$42.3B
$2.62M 0.04%
40,810
+5,260
+15% +$321K
OII icon
156
Oceaneering
OII
$5.03B
$2.55M 0.04%
39,072
+6,380
+20% +$441K
SAP icon
157
SAP
SAP
$225B
$2.53M 0.04%
35,025
-225
-0.6% -$17.5K
HMN icon
158
Horace Mann Educators
HMN
$2.1B
$2.48M 0.04%
86,789
+15,405
+22% +$454K
SU icon
159
Suncor Energy
SU
$76.3B
$2.39M 0.04%
66,092
+840
+1% +$33.7K
COHR icon
160
Coherent
COHR
$64.5B
$2.36M 0.04%
200,212
+13,880
+7% +$189K
TGT icon
161
Target
TGT
$67.5B
$2.35M 0.04%
37,490
-15,208
-29% -$921K
GILD icon
162
Gilead Sciences
GILD
$165B
$2.29M 0.03%
21,556
+356
+2% +$34.9K
ES icon
163
Eversource Energy
ES
$27.4B
$2.28M 0.03%
51,541
-149
-0.3% -$6.7K
PNY
164
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$2.22M 0.03%
66,240
-2,400
-3% -$86.1K
BF.B icon
165
Brown-Forman Class B
BF.B
$13B
$2.22M 0.03%
76,819
-781
-1% -$22.9K
PSMT icon
166
Pricesmart
PSMT
$6.04B
$2.18M 0.03%
25,417
+2,035
+9% +$177K
NBL
167
DELISTED
Noble Energy, Inc.
NBL
$2.16M 0.03%
31,610
-302
-0.9% -$21.5K
V icon
168
Visa
V
$690B
$2.13M 0.03%
39,864
+484
+1% +$26K
ORCL icon
169
Oracle
ORCL
$425B
$2.07M 0.03%
53,973
-2,487
-4% -$101K
BR icon
170
Broadridge
BR
$19.5B
$2.06M 0.03%
49,430
+17,560
+55% +$730K
GOOG icon
171
Alphabet (Google) Class C
GOOG
$4.61T
$2.03M 0.03%
69,771
+10,128
+17% +$293K
JCI icon
172
Johnson Controls International
JCI
$93.1B
$2.02M 0.03%
43,945
+1,623
+4% +$81.8K
BCR
173
DELISTED
CR Bard Inc.
BCR
$1.95M 0.03%
13,661
-80
-0.6% -$11.8K
TXRH icon
174
Texas Roadhouse
TXRH
$13.7B
$1.91M 0.03%
68,727
+16,755
+32% +$436K
SPY icon
175
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$1.91M 0.03%
9,674
+140
+1% +$27.7K

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.